Versor Investments LP Haemonetics Corp Transaction History

Versor Investments LP

$623 Million
Q3 2024

A detailed history of Versor Investments LP transactions in Haemonetics Corp stock. As of the latest transaction made, Versor Investments LP holds 3,600 shares of HAE stock, worth $307,548. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,600

Previous 3,300 9.09%

Holding current value

$307,548

Previous $273,000 5.86%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$72.45 - $91.58 $21,735 - $27,474	300 Added 9.09%	3,600 $289,000
Q2 2024 Aug 01, 2024	BUY	$81.24 - $97.37 $268,092 - $321,321	3,300 New	3,300 $273,000
Q4 2023 Feb 07, 2024	SELL	$80.59 - $92.61 $3,545 - $4,074	-44 Reduced 0.55%	7,921 $677,000
Q3 2023 Nov 06, 2023	BUY	$82.56 - $93.49 $300,435 - $340,210	3,639 Added 84.12%	7,965 $713,000
Q2 2023 Aug 07, 2023	SELL	$80.84 - $89.45 $161,114 - $178,273	-1,993 Reduced 31.54%	4,326 $368,000
Q1 2023 May 05, 2023	SELL	$72.75 - $90.6 $384,192 - $478,458	-5,281 Reduced 45.53%	6,319 $522,000
Q4 2022 Jan 30, 2023	BUY	$73.85 - $86.14 $517,614 - $603,755	7,009 Added 152.67%	11,600 $912,000
Q3 2022 Oct 25, 2022	BUY	$63.3 - $78.66 $290,610 - $361,128	4,591 New	4,591 $340,000
Q1 2019 May 09, 2019	SELL	$83.25 - $102.12 $179,570 - $220,272	-2,157 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $235,716 - $303,238	-2,600 Reduced 54.66%	2,157 $216,000
Q3 2018 Oct 25, 2018	BUY	$89.96 - $114.58 $8,996 - $11,458	100 Added 2.15%	4,757 $545,000
Q1 2018 May 01, 2018	BUY	$60.72 - $74.41 $282,773 - $346,527	4,657 New	4,657 $341,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.38B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.

Account

Versor Investments LP Haemonetics Corp Transaction History